| Q34137679 | A review of the use of corticosteroids in the management of pulmonary injuries and insults |
| Q71146339 | ARDS: new insights and unsolved problems |
| Q34053411 | Acute respiratory distress syndrome. Potential pharmacologic interventions |
| Q33394357 | Beyond thrombosis: the versatile platelet in critical illness |
| Q74512169 | Changes in the lungs of lambs after intratracheal injection of lipopolysaccharide from Pasteurella haemolytica A1 |
| Q36078070 | Corticosteroids in acute respiratory distress syndrome |
| Q70252497 | Corticosteroids in the Treatment of Septic Shock and the Adult Respiratory Distress Syndrome |
| Q39595306 | Corticosteroids, nonsteroidal anti-inflammatory drugs, and naloxone in the sepsis syndrome |
| Q39705079 | Critical care complications in the trauma patient. |
| Q39755512 | Current perspectives on septic shock |
| Q42169115 | Effect of corticosteroid on lung parenchyma remodeling at an early phase of acute lung injury |
| Q33821784 | Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep |
| Q34620035 | Effects of platelet depletion on the unanesthetized sheep's pulmonary response to endotoxemia |
| Q40981115 | Increased Immunoreactive Rat Lung Icam-1 in Oleic Acid-Induced Lung Injury |
| Q44919350 | Lung albumin accumulation is spatially heterogeneous but not correlated with regional pulmonary perfusion |
| Q42124188 | Mechanical versus humoral determinants of brain death-induced lung injury. |
| Q40134567 | Mediators of septic lung injury |
| Q42009930 | Modification by steroids of pulmonary oedema and prostaglandin E2 pharmacokinetics induced by endotoxin in rats |
| Q36441157 | Ocular albumin fluorophotometric quantitation of endotoxin-induced vascular permeability |
| Q42154352 | Plasma acid phosphatase levels in endotoxaemia: modification by drugs and chemically detoxified endotoxins |
| Q45997992 | Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. |
| Q40150237 | Prostaglandin and Thromboxane Mediation of Cardiopulmonary Failure |
| Q69920475 | Pulmonary edema |
| Q43746118 | Research on ibuprofen for sepsis and respiratory failure |
| Q70222282 | Respiratory insufficiency |
| Q40108742 | Septicemia and Lung Injury |
| Q40148203 | The Adult Respiratory Distress Syndrome |
| Q40180386 | The case for steroids: another viewpoint |
| Q40214279 | The effects of group B streptococcus and other organisms on the pulmonary vasculature. |
| Q70498707 | The importance of anti-lipid A (anti-endotoxin): prevention of "shock lung" and acute renal failure |
| Q44996293 | The last 100 years of sepsis |
| Q33822272 | Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin |
| Q43595294 | Timing of corticosteroid treatment. Effect of lung lymph dynamics in air injury in awake sheep. |